Halozyme Therapeutics shares owned by Brevan Howard Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Brevan Howard Capital Management
from 13F filings
Historical chart of Brevan Howard Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Brevan Howard Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.7M | 64k | 73.34 |
| 2025-06-30 | $8.4M | 161k | 52.02 |
| 2025-03-31 | $971k | 15k | 63.81 |
| 2024-12-31 | $1.0M | 21k | 47.81 |
| 2024-06-30 | $1.0M | 20k | 52.36 |
| 2023-12-31 | $344k | 9.3k | 36.96 |
More positions owned by Brevan Howard Capital Management
View all positions for Brevan Howard Capital Management